Pathophysiology, Diagnosis, and Management of Coronary No-Reflow Phenomenon

Area of Science:

• Cardiology
• Interventional Cardiology
• Myocardial Pathophysiology

Background:

• Coronary no-reflow is a lethal complication after successful revascularization of infarct-related arteries.
• It frequently occurs after percutaneous coronary intervention, leading to adverse in-hospital and long-term outcomes.
• Mechanisms like ischemia-reperfusion injury and microthromboembolism are implicated but not fully understood in humans.

Purpose of the Study:

• To review the current understanding of coronary no-reflow phenomenon.
• To discuss its pathophysiology, clinical predictors, and diagnostic and management strategies.

Main Methods:

• Literature review of existing studies on coronary no-reflow.
• Synthesis of information on pathophysiology, clinical predictors, and treatment approaches.

Main Results:

• The exact human pathophysiology of coronary no-reflow is still unclear.
• Proposed investigative and treatment strategies have not consistently reduced mortality or prevented adverse left ventricular remodeling.
• Genetic susceptibility and endothelial dysfunction may play roles.

Conclusions:

• Further research is needed to elucidate the precise mechanisms of coronary no-reflow.
• Improved diagnostic and therapeutic strategies are required to mitigate its detrimental effects on myocardial injury and left ventricular function.